Matches in Wikidata for { <http://www.wikidata.org/entity/Q87078353> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q87078353 description "clinical trial" @default.
- Q87078353 description "ensayu clínicu" @default.
- Q87078353 description "klinisch onderzoek" @default.
- Q87078353 description "клінічне випробування" @default.
- Q87078353 name "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 name "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 type Item @default.
- Q87078353 label "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 label "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 prefLabel "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 prefLabel "Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease." @default.
- Q87078353 P1132 Q87078353-342EA7D4-5C25-4D53-88AE-F7281DE1E5FC @default.
- Q87078353 P1476 Q87078353-EAE1BD3D-20DB-4DDA-89F0-0BDF5A83D9EA @default.
- Q87078353 P1813 Q87078353-A0FD6A1E-D758-400F-9B29-0F2917D14998 @default.
- Q87078353 P2899 Q87078353-D4957EF8-0277-45C0-8D31-E1F4583CA018 @default.
- Q87078353 P3098 Q87078353-539F5DB9-2A0D-430D-A80D-BC11A533CC72 @default.
- Q87078353 P31 Q87078353-001367F6-4484-44AB-B013-FBA7E1AE5E65 @default.
- Q87078353 P4135 Q87078353-13D09D9E-2954-47E8-973A-AB38B500C610 @default.
- Q87078353 P4844 Q87078353-2986EF7F-3B95-4EFD-A73A-1097FA6D8925 @default.
- Q87078353 P580 Q87078353-3A541E66-1038-4348-9A4F-EEE1CAAEFA30 @default.
- Q87078353 P582 Q87078353-17ADF1B0-45D1-418E-AEF8-6AB6F216FFCE @default.
- Q87078353 P6099 Q87078353-827AEED6-0EF8-4F4A-94FE-FDBD91CCD591 @default.
- Q87078353 P8363 Q87078353-CDB31EAC-8A21-48FA-A0DA-2E48A337A992 @default.
- Q87078353 P859 Q87078353-9E693E49-29F6-409C-AD8E-B7345D65938F @default.
- Q87078353 P921 Q87078353-78E18FFF-9520-42C5-AEA4-9C9AF034ECCA @default.
- Q87078353 P921 Q87078353-F1F87B88-B6D3-494C-ACB9-29C4273FD7E5 @default.
- Q87078353 P1132 "+182" @default.
- Q87078353 P1476 "A Randomised, Double Blind, Parallel Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing the Number of Vaso-Occlusive Crises in Paediatric Patients Aged 6 Months to <18 Years With Sickle Cell Disease (HESTIA5)" @default.
- Q87078353 P1813 "HESTIA5" @default.
- Q87078353 P2899 "+6" @default.
- Q87078353 P3098 "NCT04293172" @default.
- Q87078353 P31 Q30612 @default.
- Q87078353 P4135 "+17" @default.
- Q87078353 P4844 Q420542 @default.
- Q87078353 P580 "2020-06-30T00:00:00Z" @default.
- Q87078353 P582 "2022-10-10T00:00:00Z" @default.
- Q87078353 P6099 Q42824827 @default.
- Q87078353 P8363 Q78089383 @default.
- Q87078353 P859 Q731938 @default.
- Q87078353 P921 Q185034 @default.
- Q87078353 P921 Q420542 @default.